Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 3 hrs 48 mins

S&P Futures
5,892.50
-13.50(-0.23%)
Dow Futures
43,472.00
-46.00(-0.11%)
Nasdaq Futures
20,396.00
-87.50(-0.43%)
Russell 2000 Futures
2,291.10
-0.10(-0.00%)
Crude Oil
70.12
+0.90(+1.30%)
Gold
2,749.40
+19.40(+0.71%)

Tempest Therapeutics, Inc. (TPST)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

1.1000

-0.0500

(-4.35%)

At close: 04:00PM EDT

1.1400

+0.04

(+3.64%)

Pre-Market:

05:41AM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	27.73M
Enterprise Value	16.86M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	1.64
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	0.31

Trading Information

Stock Price History

Beta (5Y Monthly)	-2.90
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	6.0000
52 Week Low ³	0.9200
50-Day Moving Average ³	1.3058
200-Day Moving Average ³	2.7788

Share Statistics

Avg Vol (3 month) ³	4.2M
Avg Vol (10 day) ³	12.43M
Shares Outstanding ⁵	25.21M
Implied Shares Outstanding ⁶	N/A
Float ⁸	21.51M
% Held by Insiders ¹	0.24%
% Held by Institutions ¹	22.43%
Shares Short (Sep 30, 2024) ⁴	1.86M
Short Ratio (Sep 30, 2024) ⁴	5.12
Short % of Float (Sep 30, 2024) ⁴	8.91%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	7.39%
Shares Short (prior month Aug 30, 2024) ⁴	2.05M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Dec 10, 2018
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:15
Last Split Date ³	Jun 28, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-54.28%
Return on Equity (ttm)	-289.26%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-31.25M
Net Income Avi to Common (ttm)	-31.75M
Diluted EPS (ttm)	-1.6000
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	31.12M
Total Cash Per Share (mrq)	1.24
Total Debt (mrq)	20.25M
Total Debt/Equity (mrq)	119.58
Current Ratio (mrq)	2.17
Book Value Per Share (mrq)	0.69

Cash Flow Statement

Operating Cash Flow (ttm)	-25.36M
Levered Free Cash Flow (ttm)	-15.2M